The inhibition of NLRP3, via NLRP3 inflammasome knockout or cathepsin-mediated NLRP3 inhibition, has been shown to confer significant protection against IR-AKI in mice [9,13]. The gene discussed is CTSS; the disease is acute kidney injury.